Galapagos NV
GLPG
#4956
Rank
C$2.57 B
Marketcap
C$38.32
Share price
0.00%
Change (1 day)
-2.90%
Change (1 year)

EPS for Galapagos NV (GLPG)

EPS in 2026 (TTM): C-$0.76

According to Galapagos NV's latest financial reports the company's current EPS (TTM) is C-$0.56. In 2024 the company made an earnings per share (EPS) of C$1.61 a decrease over its 2023 EPS that were of C$4.90.

EPS history for Galapagos NV from 2004 to 2026

Annual EPS

Year EPS Change
2026 (TTM)C-$0.76
2024C$1.61-67.16%
2023C$4.90-199.64%
2022C-$4.9299.03%
2021C-$2.47-68.98%
2020C-$7.97-298.06%
2019C$4.03-554.64%
2018C-$0.89-77.18%
2017C-$3.88-326.21%
2016C$1.72-134.19%
2015C-$5.02-371.34%
2014C$1.85-445.98%
2013C-$0.5332.88%
2012C-$0.40-82.07%
2011C-$2.24-817.9%
2010C$0.3112.73%
2009C$0.28-120.79%
2008C-$1.33-37.67%
2007C-$2.1439.64%
2006C-$1.5328.17%
2005C-$1.206.25%
2004C-$1.12

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
C$12.07-2,244.61%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
C$4.99-985.84%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
C$2.84-604.81%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
C$3.54-728.35%๐Ÿ‡ซ๐Ÿ‡ท France
Merck
MRK
C$4.92-973.26%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
C$9.60-1,806.09%๐Ÿ‡ฌ๐Ÿ‡ง UK
GSK plc
GSK
C$5.37-1,054.01%๐Ÿ‡ฌ๐Ÿ‡ง UK
Fortress Biotech
FBIO
C-$0.84 49.74%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
C$1.89-436.31%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel